Danaher (DHR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
8 May, 2026Opening remarks and agenda
Meeting called to order by the Chairman, with agenda and procedures available online.
Introduction of board members and independent auditor from Ernst & Young LLP.
Record date for voting set as March 6, 2026, with quorum confirmed.
Four items of business outlined, with no additional shareholder proposals introduced.
Board and executive committee updates
Board nominees for director positions presented for election to serve until the 2027 annual meeting.
Shareholder proposals
No shareholder proposals were introduced for consideration at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Danaher
- Bioprocessing and diagnostics drive growth outlook, with Masimo acquisition boosting long-term returns.DHR
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Q1 2026 revenue up 3.5% to $6.0B, adjusted EPS up 9.5%, Masimo acquisition announced.DHR
Q1 202621 Apr 2026 - Strong 2025 results, robust recurring revenue, and innovation drive long-term growth outlook.DHR
Corporate presentation21 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at May 2026 meeting.DHR
Proxy filing25 Mar 2026 - 2026 proxy covers director elections, pay, auditor, incentive plan, and major acquisition.DHR
Proxy filing25 Mar 2026 - 2025 ended with strong growth and cash flow; 2026 guidance targets higher revenue and EPS.DHR
Q4 20253 Feb 2026 - Q2 2024 revenue fell 3%, margin improved, and $4.6B was spent on share repurchases.DHR
Q2 20243 Feb 2026 - High single-digit growth and margin expansion driven by innovation and global diagnostics leadership.DHR
Investor Day 202422 Jan 2026 - Q3 revenue up 3%, adjusted EPS $1.71, but core sales and net earnings face headwinds.DHR
Q3 202419 Jan 2026